STEPHANIE BENSON: Open Payments
NPI 1689303679 · SMITHFIELD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 39 payments from 19 companies in 2025. Trend: 2023 $469 · 2024 $1,020 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $225 |
| Novo Nordisk Inc | 5 | $92 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $30 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| KYOWA KIRIN, INC. | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: VRAYLAR, Wegovy, SHINGRIX, QULIPTA, Ozempic, FARXIGA, TZIELD, NEFFY.
Industry payments across NC — which companies pay providers there.
